Key facts
- This page summarizes Rebecca Seidel's Form 4 filing for Clearfield, Inc. (CLFD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2026, 17:16.
Rebecca Seidel - 27 Feb 2026 Form 4 Insider Report for Clearfield, Inc. (CLFD)
- Reporting relationship
- Director
- Issuer ticker
- CLFD
- Reported as of
- 27 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2026, 17:16:23 UTC
- Prior SEC filing
- 11 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- Darrell Hammond by Power of Attorney for Rebecca Seidel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rebecca Seidel filed Form 4 for Clearfield, Inc. (CLFD) on 02 Mar 2026.
Change
- Previous filing in this sequence was filed on 11 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002097541
Primary reporting owner
Seidel Rebecca
- Relationship
- Director
- Address
- 7050 WINNETKA AVE N STE 100, BROOKLYN PARK
- Signature
- Darrell Hammond by Power of Attorney for Rebecca Seidel
- Signature date
- 02 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLFD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,544
- Change %
- +780%
- Price
- $0.000000
- Shares after
- 2,870
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restrictions on Restricted Stock lapse the first business day prior to the 2027 Annual Meeting of Shareholders.